Possible neuroleptic malignant syndrome with quetiapine
نویسندگان
چکیده
منابع مشابه
Olanzapine-Induced Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical antipsychotic, but it seems that its incidence is rising due to increased administration of such drug...
متن کاملSuspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration.
Neuroleptic malignant syndrome (NMS) is a physiologic phenomenon that has been associated with the use of both first- and second-generation antipsychotics resultant to their ability to block dopamine blockade in the basal ganglia and hypothalamic regions of the brain. The typical reaction involves the presentation of muscle rigidity, changes in mental status, temperature elevation, labile blood...
متن کاملQuetiapine Poisoning Associated with Neuroleptic Malignant Syndrome, Rhabdomyolysis and Renal Failure: A Case Report.
QUETIAPINE POISONING ASSOCIATED WITH NEUROLEPTIC MALIGNANT SYNDROME, RHABDOMYOLYSIS AND RENAL FAILURE: A CASE REPORT Željko Ninčević, Davor Lasić, Trpimir Glavina, Marijana Mikačić, Mladen Carev & Kristian Podrug Department of Anaesthesiology and Intensive Care Medicine, University Hospital Centre Split, Split, Croatia Department of Psychiatry, University Hospital Centre Split, Split, Croatia D...
متن کاملNeuroleptic malignant syndrome.
The neuroleptic malignant syndrome is an uncommon, severe illness that consists of fever, muscular rigidity, and stupor. Various neuroleptics have been associated with the disease. A detailed neurological, medical, and neuropathological evaluation of this case was performed. Presumably, the syndrome is secondary to biochemical dysfunction of the basal ganglia and possible of the hypothalmus.
متن کاملNeuroleptic malignant syndrome.
We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol. When brought to the emergency department, he was comatose, hypotensive, and had rigid muscle tone and a core body temperature of 42.2 C. Although initial treatment was supportive, intubation, ventilator support, a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 2000
ISSN: 0007-1250,1472-1465
DOI: 10.1192/bjp.176.5.497-a